Scholarly Index
Jacques Fantini
Inserm; 11,936 total citations; 271 total publications; best world rank #58
Inserm
11,936Total citations
271Total publications
61H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| SARS-CoV-2 and COVID-19 Research | Lifetime | 579 | FR 19 | 98.13 |
| Glycosylation and Glycoproteins Research | Lifetime | 771 | FR 20 | 97.87 |
| Lipid Membrane Structure and Behavior | Lifetime | 497 | FR 18 | 98.03 |
| HIV Research and Treatment | Lifetime | 715 | FR 37 | 98.28 |
| Sphingolipid Metabolism and Signaling | Lifetime | 301 | FR 11 | 95.38 |
| Lipid Membrane Structure and Behavior | 2021-2025 | 58 | FR 4 | 95.86 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 979 | FR 31 | 96.45 |
| Glycosylation and Glycoproteins Research | 2021-2025 | 362 | FR 5 | 89.46 |
| Hereditary Neurological Disorders | 2021-2025 | 171 | FR 12 | 84.75 |
| vaccines and immunoinformatics approaches | 2021-2025 | 647 | FR 3 | 78.93 |
| Cellular transport and secretion | 2021-2025 | 864 | FR 40 | 71.05 |